BGMA Backs UK COVID-19 Recovery Roadmap
Suggests UK Government, NHS And Life Sciences Sector Work Together
Putting forward a roadmap for recovery from COVID-19, the ‘Life Sciences COVID-19 Response Group,’ established in March 2020, has insisted that positive factors introduced during the COVID-19 pandemic should be enhanced and retained.
You may also be interested in...
The US FDA’s ‘Purple Book’ which was created “to improve transparency and functionality for stakeholders by providing a complete view of biological product options” has been updated after being recently transitioned into an online database.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.
Alvogen’s newly created B2B unit, Adalvo, has partnered with AmbioPharm for the co-development and licensing for the commercialization of several complex pharmaceutical products, including difficult-to-make peptides, in key global markets.